News-Medical.Net on MSN
Alzheimer’s plaques decline after CAR-T immune cell treatment in preclinical study
By Hugo Francisco de Souza A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the ...
Namibian Sun on MSN
Peptide therapy: The future of targeted treatment?
Peptide therapy consists of a unique pharmaceutical class of agents that are constructed of a range of organized amino acids.
Just making these organoids was a big advance in spinal research, so the success of the so-called “dancing molecules” treatment represents fresh hope.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results